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Abstract
Intrauterine presence of Porphyromonas gingivalis (Pg), a common oral pathobiont, is impli-
cated in preterm birth. Our aim was to determine if the location of Pg within placental and/or
umbilical cord sections was associated with a specific delivery diagnosis at preterm delivery
(histologic chorioamnionitis, chorioamnionitis with funisitis, preeclampsia, and preeclamp-
sia with HELLP-syndrome, small for gestational age). The prevalence and location of Pg
within archived placental and umbilical cord specimens from preterm (25 to 32 weeks gesta-
tion) and term control cohorts were evaluated by immunofluorescent histology. Detection of
Pg was performed blinded to pregnancy characteristics. Multivariate analyses were per-
formed to evaluate independent effects of gestational age, being small for gestational age,
specific preterm delivery diagnosis, antenatal steroids, and delivery mode, on the odds of
having Pg in the preterm tissue. Within the preterm cohort, 49 of 97 (51%) placentas and 40
of 97 (41%) umbilical cord specimens were positive for Pg. Pg within the placenta was sig-
nificantly associated with shorter gestation lengths (OR 0.63 (95%CI: 0.48–0.85; p = 0.002)
per week) and delivery via caesarean section (OR 4.02 (95%CI: 1.15–14.04; p = 0.03), but
not with histological chorioamnionitis or preeclampsia. However, the presence of Pg in the
umbilical cord was significantly associated with preeclampsia: OR 6.73 (95%CI: 1.31–
36.67; p = 0.02). In the term cohort, 2 of 35 (6%) placentas and no umbilical cord term speci-
mens were positive for Pg. The location of Pg within the placenta was different between pre-
term and term groups in that Pg within the villous mesenchyme was only detected in the
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preterm cohort, whereas Pg associated with syncytiotrophoblasts was found in both pre-
term and term placentas. Taken together, our results suggest that the presence of Pg within
the villous stroma or umbilical cord may be an important determinant in Pg-associated
adverse pregnancy outcomes.
Introduction
Every year 15 million babies are born preterm [1], one million of these babies die due to com-
plications of preterm birth [2]. Those who survive are at risk for serious morbidity such as
adverse neurodevelopmental outcomes [3], chronic lung disease (e.g. bronchopulmonary dys-
plasia) [4], and asthma [5]. Intrauterine infection is one of the most common causes of preterm
deliveries [1, 3, 6], and ascending infection into the amniotic cavity is considered the core
mechanism [3]. Recent studies indicate that oral bacteria, which comprise a highly diverse
microbiome, may also play an important role in the pathogenesis of preterm delivery [3, 7–11].
There are two principle biological mechanisms whereby periodontal bacteria are thought to
promote adverse pregnancy outcomes [11]. The first model refers to an indirect pathway
through which pro-inflammatory mediators released from damaged periodontal tissues reach
the fetal–placental unit via the circulation. The second model proposes that microorganisms
and/or their components directly reach the fetal–placental unit via hematogenous dissemina-
tion from the oral cavity or, less likely, by ascending route from the lower genitourinary tract.
Although these models form the basis of the current periodontal treatment guidelines for preg-
nant women, they do not fully address the mechanisms by which certain periodontal bacteria
affect obstetric outcomes [11, 12]. For example, periodontal therapy during pregnancy has not
made a significant impact on the reduction of preterm birth [11, 12]. Thus, additional studies
are needed in order to better identify at risk populations, refine current therapeutic policies,
and/or develop new modes of therapy.
Porphyromonas gingivalis (Pg) is a Gram-negative anaerobic asaccharolytic bacterium and
common pathobiont of the oral cavity worldwide [13, 14]. Pg oral colonization rates range
between 10 to 25% in healthy adults and 79 to 90% in adults with periodontal disease [14]. Pg
is also implicated in a diverse array of pregnancy complications including low birth weight,
intrauterine growth restriction, preeclampsia, and spontaneous preterm birth [9, 15–18]. Pg is
considered a keystone species of periodontal disease because it produces an array of virulence
factors that subvert host immunity and promotes a persistent inflammation [13]. Through this
process Pg actually enables the emergence of dysbiotic oral communities that enhance disease
severity [13]. Under these circumstances Pg may promote preterm delivery via the indirect
pathway [11].
There is emerging evidence that Pg may contribute to adverse pregnancy outcomes by
directly invading maternal-fetal tissues. In women with preeclampsia, Pg detection rates within
the uterine compartment range between 30 and 92%; with prevalence being highest in studies
that sampled the decidua/placental basal plate [15, 17, 18]. In rodents, monotypic infection of
the utero-placental tissues produces fetal growth restriction, mild chorioamnionitis, endome-
trial arteritis, utero-placental thrombosis/hemorrhage with disruption of placental architecture,
and increased production of pro-TH1 cytokines such as TNF-α, IFN-γ, IL-1, IL-12, and IL-17
in placental tissues [19–22]. As compelling as these findings are, the circumstances or mecha-
nisms by which intrauterine infection with Pg promotes adverse pregnancy outcomes in
women remain elusive. For instance, Pg has also been found in the placental tissue of women
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with normal pregnancies, albeit at a lower microbial load and lower frequency than women
with preeclampsia or preterm birth [15–18].
Although maternal periodontitis is considered the source whereby oral bacteria gain entry
into the circulation and reach the uterine compartment, clinical measures of periodontal dis-
ease cannot adequately reflect the infectious or inflammatory burden that is actually present in
the pregnant women [11]. In this scenario, it is difficult to establish clear associations between
the presence of oral bacteria at the maternal-fetal interface and preterm delivery. Therefore, the
focus of this study was to determining if the presence of Pg within the placenta or umbilical
cord was linked to adverse pregnancy outcome. We utilized an antibody based assay to deter-
mine if the in situ presence of Pg within placental and umbilical cord sections from very pre-
term infants (25 to 32 weeks gestation) [1] was different from normal term deliveries. In
addition, a goal was to establish if Pg within placental and umbilical cord sections was linked to
specific preterm pathology such as histologic chorioamnionitis (HC); histologic chorioamnio-
nitis with funisitis as an indicator of fetal involvement (HCF); preeclampsia (PE); and pre-
eclampsia with hemolysis, elevated liver enzymes, and a low platelet count (HELLP-
syndrome). Based on the results of this study, we propose that the location of Pg within the vil-




Specimens were prospectively collected with written parental consent and appropriate Institu-
tional approval. The Rotterdam study was approved by the Medical Ethics Committee for
Research on Human Subjects of the Erasmus University MC [23]. The Utrecht study was
approved by the ethical review board of the Wilhelmina Children’s Hospital/University Medi-
cal Center Utrecht [24]. In situ detection of Pg was performed on de-identified sections with
approval of the University of Florida Institutional Review Board.
Patient and sample inclusion
Fig 1 illustrates the inclusion/exclusion scheme for both preterm and term samples. The pre-
term cohort ( 32 weeks gestation) consisted of newborns born in the Erasmus Medical Cen-
ter-Sophia Children’s Hospital, Rotterdam, The Netherlands, between May 2001 and February
2003 [23]. Patient characteristics of included (Table 1) and excluded preterm subjects are sum-
marized in S1 Table. The term cohort consisted of newborns born following spontaneous onset
of labor and vaginal delivery in the outpatient labor and delivery ward of the Wilhelmina Chil-
dren’s Hospital in Utrecht, The Netherlands, between January 2006 and November 2007
(Table 1) [24]. In both cohorts, infants were excluded if major congenital abnormalities were
present.
Gestational age was extracted from the medical records, and the determination of the
method of ascertainment was thus at the discretion of the attending obstetrician. For each
delivery we recorded the following: maternal age, gravidity, parity, antenatal steroid adminis-
tration (betamethasone 12 mg intramuscularly, repeated after 24 hours), preterm premature
rupture of membranes (PPROM), placental weight and delivery mode. We also documented
whether there was a clinical diagnosis of preeclampsia and whether or not this diagnosis was
accompanied by HELLP-syndrome. Preeclampsia was defined by new onset hypertension after
20 weeks gestation, accompanied by proteinuria (>300mg/24 hours). Hypertension was
defined as a resting blood pressure>140/90 mmHg or mean arterial pressure>105 mmHg
recorded on at least two separate occasions [23].
P. gingivalis and Adverse Pregnancy Outcome
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Collected neonatal data included 1, 5 and 10 minute Apgar-scores, infant gender, perinatal
mortality and birth weight. A birth weight less than the 10th centile for gestational age was con-
sidered small for gestational age (SGA) [23].
Tissue collection and placental histology
Placentas, and umbilical cords were collected immediately after each delivery. Placentas with
membranes and umbilical cord were fixed for 24–48 hours. The placenta was cut in slices of
1–2 cm to determine the presence of macroscopical lesions. Two umbilical cord blocks (one
from the fetal and one from the placental end of the umbilical cord), and three blocks of nor-
mal placental parenchyma (sampled from the central area of the placenta) were embedded in
paraffin, processed and stained with hematoxylin and eosin.
Placental and umbilical cord samples were assessed for signs of HC by determining the
presence of polymorphonuclear cells present in the chorionic plate or membranous chorionic
connective tissue and/or the amnion, as suggested by the Amniotic Fluid Infection Nosology
Committee [25]. The diagnosis of HCF included any of the following features: chorionic vas-
culitis, umbilical phlebitis, umbilical (pan) vasculitis, (sub-acute) necrotizing funisitis, or con-
centric umbilical perivasculitis [25]. Ninety-seven preterm placental and cord samples from
singleton deliveries were of acceptable morphological quality for immunofluorescent
analysis.
Fig 1. Flow chart of sample inclusion.
doi:10.1371/journal.pone.0146157.g001
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Immunofluorescent studies
Two serial sections from each placenta and umbilical cord specimen were examined for the
presence of Pg antigen. Pg antigen was detected with a rabbit polyclonal antiserum diluted at
1:2000 [26], which was confirmed to recognize several strains of Pg [26], and validated for
specificity (S1A Fig). With each experiment, a separate section that was incubated with pre-
immune serum from the same rabbit host was included to define non-specific binding (S1B
Fig).
Trophoblasts were detected with a cytokeratin 7-specific mouse monoclonal antibody
(Abcam1, Cambridge, MA) [27]. Myofibroblasts were detected with a vimentin-specific
mouse monoclonal antibody (Abcam1, Cambridge, MA) [28]. Goat anti-rabbit ALEXA 594
(absorption 590, emission 617) and goat anti-mouse ALEXA 488 (absorption 495, emission
519) (Life Technologies™, Grand Island, NY) were used as secondary antibodies. Cell nuclei
were stained with 40,6-diamidino-2-phenylindole (DAPI). All stained sections were evaluated
with an Olympus IX81-DSU Spinning Disk confocal microscope using Slidebook software
(Olympus, Center Valley, PA). In order to avoid bias, detection of Pg was performed by a single
examiner (LR) blinded to placental pathology and other clinical information. The entire section
was examined for the presence of Pg. A specimen was considered positive when the two serial
sections showed a clear fluorescent signal for the Pg antigen.
A semi-quantitative scoring system was developed to quantify the Pg antigen load per
patient. Pg specimens that were negative on all examined sections were assigned a score of 0.
Specimens with one aggregate of Pg antigen per section were considered scant staining and
were assigned a score of 1. Sections that had more than one Pg aggregate in at least one of the
sections examined were considered moderate antigen load and assigned a score of 2. Sections
Table 1. Clinical characteristics of included subjects.
Preterm newborns (n = 97) Term newborns (n = 35) P value
Maternal age (years) 31 ± 6 31 ± 5 0.79
Gravidity 2 (1–3) 2 (1–3) 0.99
Parity 0 (0–1) 1 (0–2) 0.60
Gestational (weeks) 29 ± 2 40 ± 1 <0.001
Full course antenatal steroids 70 (72%) 0 <0.001
PPROM 26 (27%) 0 0.001
Caesarean section 65 (67%) 0 <0.001
Placenta weight (grams) 260 ± 85 473 ± 78 <0.001
Preterm reference group 17 (18%) 28 (80%) <0.001
HC 18 (19%) 6 (17%)
HCF 23 (24%) 1 (3%)
Preeclampsia 14 (14%) 0
Preeclampsia + HELLP 25 (26%) 0
Male gender 56 (58%) 20 (57%) 0.95
Birth weight (grams) 1162 ± 340 3501 ± 436 <0.001
SGA 23 (24%) 0 0.002
In-hospital mortality 13 (13%) 0 0.025
Numbers represent number and percentage of newborns or mothers in which characteristic is present for categorical data; median and interquartile range
for ordinal data; and mean ± SD for continuous data. Differences between the included preterm and term subjects were tested using Chi-square, Mann-
Whitney U and Student t-test, as appropriate. Abbreviations: PPROM, preterm premature rupture of membranes; HELLP, hemolysis, elevated liver
enzymes and low platelet count; HC, histologic chorioamnionitis; HCF, histologic chorioamnionitis with funisitis; SGA, small for gestational age.
doi:10.1371/journal.pone.0146157.t001
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with more than one Pg aggregate on all sections examined were considered heavy antigen load
and assigned a score of 3.
Statistical analysis
This study was executed in two stages. Preterm placenta and cord samples were analyzed in the
first stage. Chi-square test was used to compare the number of Pg positive samples within the
preterm cohort based on gestational age and adverse pregnancy characteristic. Dunnett’s post-
hoc analysis was used to compare each pathology group to the preterm reference group. Logis-
tic regression analyses of the preterm cohort were also performed to evaluate the independent
effects of gestational age (in weeks), specific preterm pathology (HC, HCF, PE, PE+HELLP),
SGA, exposure to antenatal steroids (full course) and mode of delivery (vaginal vs caesarean
section) on the odds of having Pg in the preterm placenta and/or cord.
In addition, we assessed Pg density according to specific preterm pathology using the Krus-
kal-Wallis test. We conducted a cumulative odds ordinal logistic regression with proportional
odds to determine whether specific pregnancy and delivery characteristics were independently
associated with Pg density in the placenta and umbilical cord. The assumption of proportional
odds was met for the ordinal regression models for Pg density in the placenta and the umbilical
cord, and both models were a good fit to the observed data.
Using results from the preterm cohort, we performed a power-analysis (alpha of 0.05 and a
power 0.80) to determine the sample size of term placentas needed. Based on this calcula-
tion, we included placental samples from 35 healthy term births in consecutive order of deliv-
ery (Fig 1).
Statistics were computed using SPSS 21.0 software (SPSS, Inc., Chicago, IL). Differences
between groups were considered statistically significant at a two-sided probability value of
<0.05.
Results
Pg prevalence in preterm placenta but not umbilical cord is linked to
shorter gestation
In the preterm cohort, Pg was present in 49 of 97 placental sections (51%). Of the positive sam-
ples, the distribution of scant, moderate, and heavy staining for Pg antigen was: 9 of 49 (18%),
30 of 49 (61%), and 10 of 49 (20%) respectively. Overall, the gestational length of preterm Pg
positive placental specimens was shorter than Pg negative specimens, with mean gestational
age ± SD being 28.8 ± 1.6 weeks vs. 29.8 ± 1.8 weeks respectively (P = 0.008). We next grouped
the frequency of Pg positive placental sections according to gestational age (weeks) at delivery
(Fig 2). The proportion of Pg positive placentas was highest at 27 weeks gestation (78%), after
which the prevalence gradually decreased as gestational age increased: adjusted odds ratio
(aOR) of 0.63 (95%CI: 0.48–0.85; p = 0.002) per week (Table 2). In line with these results,
increasing gestational age (expressed in weeks) was less likely to have a heavy Pg density in the
placenta, [aOR of 0.69 (95% CI: 0.53–0.89; p = 0.004)] (Table 3, S2a Fig). Pg positivity within
the placenta was 4.02 times more likely to require delivery via caesarean section [aOR of 4.02
(95%CI: 1.15–14.04; p = 0.03)] (Table 2) and only 25% of caesarean sections were likely to have
heavy Pg density in the placenta, [aOR of 0.25 (0.08–0.76; p = 0.01)] (Table 3). In contrast,
there were no independent associations between antenatal steroid treatment or SGA and pres-
ence of Pg or Pg density in the placenta (Tables 2 and 3).
Forty of 97 (41%) preterm umbilical cord sections were positive for Pg. Within the positive
group, the distribution of scant, moderate and heavy staining for Pg antigen was: 6 of 40 (15%),
P. gingivalis and Adverse Pregnancy Outcome
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25 of 40 (62%), and 9 of 40 (23%) respectively. There was no independent association between
the presence of Pg or Pg density within the umbilical cord and gestational age, antenatal steroid
treatment, or mode of delivery (Tables 2 and 3).
Since we observed a significant association between Pg positivity in the placenta and shorter
gestation length, we postulated that the proportion of Pg positive specimens in term pregnancy
would be lower than in pregnancies ending prematurely. Because term specimens were not
available for study in the Rotterdam cohort, we obtained archived term pregnancy specimens
from a prospective cohort collected at Wilhelmina Children’s Hospital/University Medical
Center Utrecht [24]. In the term cohort, Pg was detected in only 2 of the 35 (6%) placental
Fig 2. The distribution of Pg positive placental sections according to gestational age.
doi:10.1371/journal.pone.0146157.g002
Table 2. Multivariable analyses of association between tissue Pg positivity and pregnancy and delivery characteristics in preterm cases.
Pg placenta and/or cord Pg cord Pg placenta
aOR (95%CI) P value aOR (95%CI) P value aOR (95%CI) P value
Gestational age (per week increase) 0.68 (0.51–0.91) 0.01 1.11 (0.85–1.45) 0.44 0.63 (0.48–0.85) 0.002
SGA 1.09 (0.28–4.23) 0.90 0.75 (0.22–2.51) 0.64 1.23 (0.36–4.20) 0.74
Full course of antenatal steroids 1.30 (0.44–3.80) 0.63 0.98 (0.35–2.74) 0.97 1.39 (0.48–4.00) 0.54
Caesarean section 0.74 (0.23–2.39) 0.62 0.46 (0.14–1.54) 0.21 4.02 (1.15–14.04) 0.03
Pathology group (ref = no pathology)
HC 0.55 (0.12–2.58) 0.45 0.39 (0.08–1.92) 0.25 0.65 (0.13–3.22) 0.60
HCF 0.57 (0.12–2.61) 0.47 1.04 (0.24–4.49) 0.96 0.49 (0.10–2.28) 0.36
PE 3.63 (0.55–24.06) 0.18 6.73 (1.31–34.67) 0.02 1.31 (0.25–6.95) 0.76
PE+HELLP 1.81 (0.39–8.29) 0.45 1.85 (0.44–7.78) 0.40 0.55 (0.13–2.41) 0.43
Results from logistic regression models. Abbreviations: Pg, Porphyromonas gingivalis; aOR, adjusted odds ratio; CI, conﬁdence interval; SGA, small for
gestational age; HC, histologic chorioamnionitis; HCF, histologic chorioamnionitis with funisitis; PE, preeclampsia; HELLP, hemolysis, elevated liver
enzymes and low platelet count.
doi:10.1371/journal.pone.0146157.t002
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sections. In both specimens the Pg antigen density was scant (score of 1). None of the term
umbilical cord sections were positive for Pg.
PE is associated with Pg positive status in the umbilical cord but not
placenta
We next categorized preterm placental and umbilical cord data (n = 97) according to specific
preterm pathology: HC (n = 18), HCF (n = 23), preeclampsia (n = 14), preeclampsia with
HELLP-syndrome (n = 25) and a preterm reference group in which these diagnoses were all
absent (n = 17). In brief, the reference group consisted of cases of spontaneous vaginal delivery
without HC or HCF (n = 6) and cases of delivery via cesarean section based on medical indica-
tion (n = 11; fetal distress and/or intra-uterine growth restriction). S2 Table provides further
description of the clinical characteristics of the five preterm subgroups. Pg positive status
within the placenta was not different among the groups. However, multivariate analysis
showed that PE was 6.73 times more likely to have Pg in the umbilical cord [OR 6.73 (95%CI:
1.31–36.67; p = 0.02)] but not the placenta (Table 3). There were no significant differences in
Pg density in the placenta or in umbilical cords among the preterm subgroups (Tables 2 and
3). The distribution of Pg density in placental and cord sections according to preterm subgroup
is summarized in S2b Fig and S3 Table.
The in situ localization of Pg in placenta and umbilical cord specimens
Preterm placental sections that were incubated with Pg specific antiserum displayed distinct
aggregates within the villous stroma that were not observed in sections incubated with pre-
immune serum (Fig 3A and S1C Fig). These aggregates were most commonly observed within
the extracellular matrix within the villous mesenchyme (Fig 3A and S1C Fig). On a few speci-
mens, Pg was also detected in association with fetal capillaries (endothelial cells), data not
shown. In order to confirm that these aggregates were specific for Pg, additional sections were
incubated with Pg specific anti-serum that was pre-adsorbed with formalin-fixed Pg. Speci-
mens incubated with pre-absorbed serum did not show the staining pattern that was detected
Table 3. Multivariable analyses of association between tissue Pg density and pregnancy and delivery
characteristics in preterm cases.
Pg density placenta Pg density umbilical cord
aOR (95%CI) P value aOR (95%CI) P value
Gestational age (per week increase) 0.69 (0.53–0.89) 0.004 1.10 (0.85–1.42) 0.47
SGA 0.88 (0.31–2.50) 0.81 1.03 (0.35–3.05) 0.96
Full course of antenatal steroids 0.60 (0.23–1.53) 0.28 0.83 (0.32–2.19) 0.71
Caesarean section 0.25 (0.08–0.76) 0.01 2.07 (0.65–6.57 0.22
Pathology group (ref = no pathology)
HC 1.60 (0.38–6.66) 0.52 3.06 (0.64–14.77) 0.16
HCF 1.75 (0.45–6.89) 0.42 1.10 (0.28–4.34) 0.89
PE 1.27 (0.32–5.07) 0.74 0.26 (0.06–1.11) 0.07
PE+HELLP 2.13 (0.58–7.83) 0.26 0.64 (0.16–2.45) 0.51
Results from cumulative odds ordinal logistic regression with proportional odds models. Abbreviations: Pg,
Porphyromonas gingivalis; aOR, adjusted odds ratio; CI, conﬁdence interval; SGA, small for gestational
age; HC, histologic chorioamnionitis; HCF, histologic chorioamnionitis with funisitis; PE, preeclampsia;
HELLP, hemolysis, elevated liver enzymes and low platelet count.
doi:10.1371/journal.pone.0146157.t003
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Fig 3. In situ detection of Pg in placental and umbilical cord sections from preterm and term tissues. A. Placental villous section from a preterm
specimen demonstrating the distribution of Pg (red, white arrow) within the extracellular matrix. Cytotrophoblasts/syncytiotrophoblasts (green) were detected
with cytokeratin-7 specific antibody. B. Corresponding preterm placental section stained with pre-adsorbed Pg-specific antiserum (red) and cytokeratin-7
specific antibody (green). C. Pre-term placental specimen demonstrating Pg (red, white arrow) attached to cytotrophoblasts/syncytiotrophoblasts (green).D.
Term placental villus section demonstrating Pg (red, white arrow) in association with syncytiotrophoblast (green). E. Preterm umbilical cord section
demonstrating extracellular and internalized Pg (white arrow) within the perivascular stroma, myofibroblast (green) were labelled with vimentin specific
antibody. F. Representative umbilical cord section from a term specimen, which were negative for Pg. Cell nuclei (blue) were stained with DAPI. *Indicates
autofluorescent red blood cells in maternal or fetal circulation. In all panels, magnified inserts are Pg positive regions demarcated by arrows. All scale bars
(bottom left corner) are equivalent to 10 μm, images are 400x or 600x magnification.
doi:10.1371/journal.pone.0146157.g003
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in the corresponding placental specimens incubated with Pg specific antisera (Fig 3B). This
confirmed that these aggregates contain Pg antigen. In 9 of 49 positive preterm placenta speci-
mens (18%), Pg was also observed attached to cytotrophoblasts and/or syncytiotrophoblasts
(Fig 3C). This pattern of colonization was observed in HC (n = 1), preeclampsia (n = 1), pre-
eclampsia with HELLP-syndrome (n = 5) and preterm reference group (n = 2) cases, which
ranged from 28 to 32 weeks gestation.
In term specimens positive for Pg, scant amounts of Pg antigen were detected in association
with syncytiotrophoblasts (Fig 3D), but Pg was never detected within the villous mesenchyme.
In preterm umbilical cord sections Pg was primarily detected in the umbilical arterial inti-
mal layer either in the extracellular matrix or appearing to be internalized in vimentin positive
cells that resembled smooth muscle cells or fibroblast cells (Fig 3E). Pg was occasionally
detected in Wharton’s jelly (S1C Fig) but not in the umbilical vessel lumen in any of cord speci-
mens. This staining pattern was also confirmed to be Pg antigen (Fig 3F). Pg antigen was never
detected in term umbilical cord specimens.
Discussion
Our overall objective was to ascertain if the location of Pg within placental and/or umbilical
cord sections from extremely preterm and very preterm infants (25 to 32 weeks gestation) was
different from normal term deliveries. In addition, we wanted to determine if the prevalence or
tissue distribution of Pg was associated with a particular obstetric complication such as HC,
HCF, PE or PE with HELLP-syndrome. Similar to previous reports [15, 16, 18], we found a
greater proportion of preterm placental specimens positive for Pg than normal term tissues.
Also consistent with previous studies [16] was the detection of more Pg antigen in preterm
specimens compared to term tissues. A novel finding in our study was that we detected a dis-
tinctive distribution of Pg antigen within the placenta and umbilical cord from preterm speci-
mens that was not found in term tissues. Further, the unique distribution of Pg antigen in the
villous stroma of preterm placental specimens was linked to shorter gestation length and the
need for cesarean section. Another novel finding was the association between PE and the pres-
ence of Pg antigens in the umbilical cord. Our results suggest that the location of the microbe
within the placenta or umbilical cord may be an important feature in Pg-associated adverse
pregnancy outcome.
We can only speculate as to how Pg gains entry into the placental mesenchyme. One possi-
ble explanation could be that Pg managed to cross from the maternal circulation into the
fetal tissues through the syncytiotrophoblast. This is the multi-nucleated layer of fused cyto-
trophoblasts cells covering the entire villous tree, thereby separating the maternal and fetal
compartments of the placenta [29]. However, the syncytiotrophoblast possesses robust
defense mechanisms against microbial invasion (e.g. the lack of intercellular junctions and
receptors, and resistance to receptor-independent invasion) [30–32]. Vertical transmission of
microbes through this route is therefore unlikely [31]. An exception would be a disruption in
the syncytiotrophoblast layer forming a direct port d’entrée. Alternatively, Pg may invade the
placenta through the decidua, at the uterine-trophoblast interface [31]. Here, microbes may
spread from the maternal circulation to susceptible extra-villous trophoblast cells by direct
invasion or cell-to-cell spread during implantation of the trophoblast into the uterine wall in
the first trimester of pregnancy [31, 32]. Pg efficiently invades a variety of host cell types [13,
33] including extravillous trophoblast cells [34]. Moreover, internalized Pg can escape the
host cell and invade surrounding cells [35], demonstrating that dissemination of Pg through
the uterine-trophoblast interface into the placental mesenchyme is a plausible route of
infection.
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The association of Pg in the placenta with shorter gestation and cesarean section supports
the hypothesis that the microbe in this location has a detrimental effect on placental function
or pregnancy. Surprisingly, this pattern of colonization was found in a variety of obstetric com-
plications that involve different utero-placental pathologies and clinical manifestations (PE vs.
HC and HCF). One possible explanation for this finding is the genetic heterogeneity among Pg
strains and its impact on microbial virulence and disease outcome [14, 36]. Both in vitro and in
vivo studies have demonstrated that distinct Pg strains display different behaviors in the host
and varying pathogenic potential [21, 26, 37, 38]. During pregnancy, rodents infected with Pg
strain A7436 develop uterine vasculitis, utero-placental thrombosis/hemorrhage, structural
alterations within the placental vascular layer (labyrinth), and fetal growth restriction [19–21];
pathology that is more consistent with PE [39, 40]. On the other hand, C57BL/6 mice infected
with Pg strain W83 exhibit pathology that is more consistent with HC and HCF such as disrup-
tion of the integrity of the chorioamnion, chorioamnionitis, and spontaneous preterm birth
[22].
An intriguing possibility is that Pg may be acting as a keystone species of HC and HCF by
modulating host antimicrobial defenses at the maternal fetal interface in a manner that facili-
tates invasion and overgrowth of other microbes within the fetal compartment. There is pre-
sumptive evidence that Pg can act as a keystone species at extra-oral tissue sites, including the
maternal-fetal interface. In a subcutaneous abscess model of polymicrobial infection, Pg sup-
presses neutrophil-mediated microbial killing, which enhances the survival of Fusobacterium
nucleatum without reducing inflammation [41]. In co-infection studies with Campylobacter
rectus, the presence of Pg modulates the placental response to C. rectus by reducing placental
expression of toll-like receptor 4 expression [42], which did not reduce adverse pregnancy out-
come. Rather, co-infected animals displayed decreased fecundity and fetal growth restriction
that did not occur in animals infected with C. rectus alone [42].
PE was the only obstetric complication to show a significant association with Pg in the
umbilical cord. This association may be an extension of what we detected in the placenta since
most PE cases that were positive in the cord were also positive in the placenta. In this preterm
cohort Pg was most commonly detected within the intimal layer of the umbilical artery. Since
this vessel is returning blood from the fetus to the placenta, it is unclear at this time what
impact the presence of Pg in the umbilical cord may have on the fetus.
Our study has several limitations. Although our focus was specifically on Pg, we recognize
that placental infections are often polymicrobial [15, 17, 18], and polymicrobial interactions
within the utero-fetal compartment may result in an different outcome than a monotypic infec-
tion [42]. Pg has been detected coexisting with other bacteria in the placenta [15, 17, 18], amni-
otic fluid [43], and neonatal gastric aspirates [44] from complicated pregnancies. Therefore, we
cannot discount the possibility that HC and HCF in particular, may be a consequence of other
bacterial species coexisting with Pg in the placental stroma or present in the amniotic cavity
[45, 46]. Despite this limitation we observed a strong association between the presence of Pg
within placental villous mesenchyme and shorter gestation as well as cesarean section. This
association, along with supportive findings in rodent infection studies [19–21, 47] suggest the
microbe may be exerting a detrimental effect on placental function regardless of what other
microbes may be present in the environment.
Another limitation was that tissues from term pregnancies at the Erasmus Medical Center-
Sophia Children’s Hospital, in Rotterdam were not available for comparison with the preterm
tissues. This is why term specimens fromWilhelmina Children’s Hospital in Utrecht were
included in this study. Although we confirmed that maternal age, gravidity, and parity were the
same in both cohorts, we cannot rule out the possibility that differences we observed between
preterm and term groups could be due to inherent differences in these populations. In addition,
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estimates of gestational age were extracted from the obstetric record at the time of birth, and
information of the method of ascertainment was lacking at the individual level. In cases where
gestational age was estimated by using the last menstrual period, a small degree of misclassifi-
cation may have influenced our findings, although the impact is likely to have been small [48,
49].
In summary, our study provides a novel insight into the relevance of Pg in obstetric compli-
cations that lead to preterm delivery. Specifically, we found that the presence of Pg within the
placental villous stroma was a unique feature of very preterm delivery irrespective of underly-
ing pathology associated with prematurity. We also found an association between the presence
of Pg in the umbilical cord and PE. Given that monotypic infection of the placenta with Pg pro-
motes intrauterine pathology and fetal growth restriction in experimental models [19, 21, 42],
our findings suggest that invasion of the villous or umbilical cord stroma by Pg alone or in
combination with other bacteria, may be a critical factor in the pathogenesis of Pg-associated
adverse pregnancy outcome.
Supporting Information
S1 Fig. Validation of the specificity of anti-Pg W83 and efficacy for use with formalin fixed
paraffin embedded tissues. A. The specificity of the antiserum to Pg was confirmed by immu-
noblotting against a panel of Gram negative bacteria and human cell lines: Lane 1, Pg strain
W83 (positive control); Lane 2, Fusobacterium nucleatum; Lane 3, Prevotella intermedia; Lane
4, Escherichia coli; Lane 5, Proteus mirabilis; Lane 6, Klebsiella pneumonia; Lane 7, HTR8 tro-
phoblast cells; Lane 8, BPH-1 cells; Lane 9, human umbilical vein endothelial cells; Lane 10,
Hela cells; Lane 11, fibroblasts; Lane 12 blank. Immunoblotting was performed with a 96 well
membrane-bottom filter plate- vacuum apparatus. Briefly, a PVDF membrane was loaded into
the apparatus, and 400 μl of phosphate buffered saline with 0.05% Tween-20 (PBS-Tween) was
passed through to soak the membrane. Each well was loaded with 200 μls of bacterial suspen-
sion (107 CFU/ml) or cell lysate (105 cells/ ml), in duplicate. The fluid was pulled through the
PVDF membrane by vacuum. The membrane was then blocked with Starting Block™ (TBS)
blocking buffer (Thermo Scientific, Rockford, IL) for 30 minutes at room temperature. Pg spe-
cific rabbit serum and the corresponding pre-immune serum were diluted 1:2000 in TBS block-
ing buffer. Each well received 200 μl aliquots of the diluted Pg antiserum (top row) or pre-
immune serum (bottom row), and incubated at room temperature for 2 hours. The membrane
was removed from the apparatus and washed 4 times with PBS-Tween. The entire membrane
was then immersed in goat anti-rabbit–alkaline-phosphate labeled antibody (NOVEX1, Life
Technologies, Frederick, MD) that was diluted 1:2000 in TBS Blocking buffer. After 30 minutes
at room temperature, the membrane was washed 4 times with PBS-Tween. The washed mem-
brane was then immersed in NOVEX1 AP-chromogenic substrate (Life Technologies, Freder-
ick, MD), and incubated at room temperature until a strong, distinctive purple signal was
observed in the positive control well (Lane 1). The membrane was washed once with
PBS-Tween and allowed to air dry. B. Representative images of a preterm placental section
stained with anti-Pg W83 (red, white arrow) and anti-cytokeratin 7 (green) or with corre-
sponding isotype controls. Nuclei (blue) were stained with DAPI. Images are 600x magnifica-
tion. Immunofluorescent stainings were performed as already described in the methods section
of the manuscript.
(PDF)
S2 Fig. The distribution of Pg density in the Pg positive placental and umbilical cord sec-
tions according to gestational age in weeks (A) and specific preterm pathology (B). Porphyr-
omonas gingivalis (Pg) density was scored using a semi-quantitive scale: negative, scant,
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moderate, and heavy. Reference group (n = 17) refers to preterm specimens that did not have a
histological or clinical diagnosis of HC (n = 18), HCF (n = 23), PE (n = 14), or PE + HELLP
(n = 25). Abbreviations: HC, histologic chorioamnionitis; HCF, histologic chorioamnionitis
with funisitis; PE, preeclampsia; PE+HELLP, preeclampsia with hemolysis, elevated liver
enzymes, and low platelet count.
(PDF)
S1 Table. Clinical characteristics of in- and excluded preterm subjects. Numbers represent
number and percentage of newborns or mothers in which characteristic is present for categori-
cal data; median and interquartile range for ordinal data; and mean ± SD for continuous data.
Differences between groups were tested using Chi-square, Mann-Whitney U and Student t-
test, respectively. Abbreviations used: PPROM, preterm premature rupture of membranes; HC,
histological chorioamnionitis; HCF, histological chorioamnionitis with funisitis; HELLP,
hemolysis, elevated liver enzymes and low platelet count; SGA, small for gestational age
(PDF)
S2 Table. Clinical characteristics preterm subjects according to underlying pathology.
Numbers represent number and percentage of newborns or mothers in which characteristic is
present for categorical data; median and interquartile range for ordinal data; and mean ± SD for
continuous data. Differences between groups were tested using Chi-square, Kruskal Wallis and
ANOVA, respectively. Dunnett’s post-hoc analysis was used to compare each group to the ref-
erence group. Significant differences are indicated by: P< 0.05; P< 0.01; and P< 0.001.
Abbreviations used: HC, histological chorioamnionitis; HCF, with funisitis; PE, preeclampsia;
HELLP, hemolysis, elevated liver enzymes and low platelet count; PPROM, preterm premature
rupture of membranes; SGA, small for gestational age. a) The reference group consists of all
preterm deliveries in which there was no HC, HCF, PE or PE with HELLP-syndrome.
(PDF)
S3 Table. Median Pg density values in preterm placentas and cords. Porphyromonas gingiva-
lis (Pg) density was scored using a semi-quantitative scale: negative, scant, moderate, and
heavy. Numbers represent the median Pg density score per group with interquartile range. Dif-
ferences in Pg density between groups were tested using Kruskal-Wallis test. Abbreviations:
HC, histologic chorioamnionitis; HCF, histologic chorioamnionitis with funisitis; PE, pre-
eclampsia; HELLP, hemolysis, elevated liver enzymes and low platelet count.
(PDF)
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